Terms: = Cervical cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
17 results:
1. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Sharma H; Parekh S; Pujari P; Shewale S; Desai S; Bhatla N; Joshi S; Pimple S; Kawade A; Balasubramani L; Thomas A; Suri V; Lalwani S; Uday R; Kamath V; Mandal R; Rajeswar A; Peedicayil A; Poli UR; Banerjee D; Sankaranarayanan R; Basu P; Muwonge R; Gairola S; Dogar V; Rao H; Shaligram U
Lancet Oncol; 2023 Dec; 24(12):1321-1333. PubMed ID: 37949086
[TBL] [Abstract] [Full Text] [Related]
2. Ultrasound-based Nomogram for Predicting the Pathological Nodal Negativity of Unilateral Clinical N1a Papillary Thyroid Carcinoma in Adolescents and Young Adults.
Wei Y; Sun P; Chang C; Tong Y
Acad Radiol; 2023 Sep; 30(9):2000-2009. PubMed ID: 36609031
[TBL] [Abstract] [Full Text] [Related]
3. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract] [Full Text] [Related]
4. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
Manzour N; Núñez-Cordoba JM; Chiva L; Chacón E; Boria F; Vara-García J; Rodriguez-Velandia YP; Minguez JA; Alcazar JL
Gynecol Oncol; 2022 Feb; 164(2):455-460. PubMed ID: 34848071
[TBL] [Abstract] [Full Text] [Related]
5. Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation.
Nomura K; Iizuka T; Kaji D; Asano-Mori Y; Ochiai Y; Suzuki Y; Hayasaka J; Yamashita S; Matsui A; Kikuchi D; Taniguchi S; Takazawa Y; Hoteya S
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2137-2144. PubMed ID: 33387042
[TBL] [Abstract] [Full Text] [Related]
6. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract] [Full Text] [Related]
7. How Do Women Interpret the NHS Information Leaflet about cervical cancer Screening?
Okan Y; Petrova D; Smith SG; Lesic V; Bruine de Bruin W
Med Decis Making; 2019 Oct; 39(7):738-754. PubMed ID: 31556840
[No Abstract] [Full Text] [Related]
8. Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database.
Yang J; Cai H; Xiao ZX; Wang H; Yang P
Medicine (Baltimore); 2019 Jul; 98(30):e16421. PubMed ID: 31348242
[TBL] [Abstract] [Full Text] [Related]
9. CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
Lee S; Ho JY; Liu JJ; Lee H; Park JY; Baik M; Ko M; Lee SU; Choi YJ; Hur SY
Mol Med; 2019 May; 25(1):23. PubMed ID: 31138113
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Scholl S; Popovic M; de la Rochefordiere A; Girard E; Dureau S; Mandic A; Koprivsek K; Samet N; Craina M; Margan M; Samuels S; Zijlmans H; Kenter G; Hillemanns P; Dema S; Dema A; Malenkovic G; Djuran B; Floquet A; Garbay D; Guyon F; Colombo PE; Fabbro M; Kerr C; Ngo C; Lecuru F; Campo ERD; Coutant C; Marchal F; Mesgouez-Nebout N; Fourchotte V; Feron JG; Morice P; Deutsch E; Wimberger P; Classe JM; Gleeson N; von der Leyen H; Minsat M; Dubot C; Gestraud P; Kereszt A; Nagy I; Balint B; Berns E; Jordanova E; Saint-Jorre N; Savignoni A; Servant N; Hupe P; de Koning L; Fumoleau P; Rouzier R; Kamal M
EBioMedicine; 2019 May; 43():253-260. PubMed ID: 30952619
[TBL] [Abstract] [Full Text] [Related]
11. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.
Kyrgiou M; Athanasiou A; Kalliala IEJ; Paraskevaidi M; Mitra A; Martin-Hirsch PP; Arbyn M; Bennett P; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012847. PubMed ID: 29095502
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract] [Full Text] [Related]
13. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract] [Full Text] [Related]
14. Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties.
Virk-Baker MK; Martin MY; Levine RS; Wang X; Nagy TR; Pisu M
Cancer Causes Control; 2013 Dec; 24(12):2187-96. PubMed ID: 24077760
[TBL] [Abstract] [Full Text] [Related]
15. Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix.
Hwang JH; Lim MC; Seo SS; Park SY; Kang S
Jpn J Clin Oncol; 2011 May; 41(5):624-9. PubMed ID: 21355002
[TBL] [Abstract] [Full Text] [Related]
16. Bladder dose estimation during intracavitary brachytherapy for carcinoma of the cervix using a single line source system.
Tan LT; Warren J; Freestone G; Jones B
Br J Radiol; 1996 Oct; 69(826):953-62. PubMed ID: 9038532
[TBL] [Abstract] [Full Text] [Related]
17. Long term results of treatment of carcinoma of cervix.
Jolles B
Br J Obstet Gynaecol; 1980 Apr; 87(4):315-21. PubMed ID: 7426501
[TBL] [Abstract] [Full Text] [Related]
